IFF’s Philippe Horvath Inducted into The National Inventors Hall of Fame

Rhea-AI Summary

Philippe Horvath, a distinguished molecular biologist and technical fellow at IFF, is inducted into the National Inventors Hall of Fame® Class of 2023 for his contributions to CRISPR technology. His patents have enhanced starter cultures in the dairy industry, significantly impacting global food supply and gene editing advancements. The ceremony will take place in October 2023 in Washington, D.C. IFF expresses pride in Horvath's achievements, highlighting the importance of scientific innovation and the ongoing fight against viral infections in food fermentation.

Positive

• Philippe Horvath's induction into the National Inventors Hall of Fame acknowledges significant contributions to CRISPR technology.
• The CRISPR advancements have potential for applications in food industry and gene editing, which could enhance IFF's market position.

Negative

• None.

Molecular biologist honored for contributions to science, enhancing global food supply and laying the foundation for gene editing

NEW YORK--(BUSINESS WIRE)-- Philippe Horvath—renowned molecular biologist and IFF technical fellow—is being inducted into the National Inventors Hall of Fame® Class of 2023. Horvath will be formally honored for two patents related to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) sequences and associated Cas proteins, that constitute an acquired immune system in bacteria. Applying this research to enhance starter cultures in the dairy industry, Horvath and research partner Rodolphe Barrangou improved the world’s food supply and laid the foundation for the field of gene editing. The formal induction will take place during a ceremony in October 2023 in Washington, D.C.

“IFF congratulates Philippe on this unique recognition,” said Gregory Yep, chief research & development, global integrated solutions and sustainability officer. “We are proud of the achievements made by Philippe and the entire CRISPR team. It is a great testament to our heritage of scientific innovation and the ability to create a better world.”

Horvath’s initial article, published in Science in 2007, provided the first biological evidence that CRISPR-Cas constitutes an immunity system against viruses in bacteria. IFF scientists were among the first to understand how the CRISPR system works in bacteria. Beginning in the early 2000s, Horvath and colleagues initially utilized CRISPR for bacterial identification, then for its ability to improve the resistance of starter culture strains against bacteriophage attack. The discoveries opened new research avenues and laid the groundwork that inspired numerous scientists to pursue the CRISPR field.

“I am deeply honored to be selected by the National Inventors Hall of Fame to represent the pioneering work our team has done,” said Horvath. “Our findings, which were focused on the natural CRISPR-Cas system, will continue to have a significant impact in the fight against viral infections during food fermentations and are finding new applications in tools for genome editing, including opportunities in plant improvement and gene therapy.”

Based at IFF’s site in Dangé-Saint-Romain, France, Horvath already has been honored with four of the world’s leading science awards: the 2015 Massry Prize, the 2016 Warren Alpert Foundation Prize, the 2016 Canada Gairdner International Award, and the 2018 Bower Award and Prize for Achievement in Science.

Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.

© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005853/en/

Paula Heinkel

Head of Global Communications

332-877-5339

Media.request@iff.com

Michael Bender

Director of Investor Relations

212-708-7263

Investor.Relations@iff.com

Source: IFF

FAQ

Why is Philippe Horvath being recognized by the National Inventors Hall of Fame?

Philippe Horvath is honored for his contributions to CRISPR technology, crucial for advancements in food supply and gene editing.

What patents did Philippe Horvath contribute to?

Horvath holds patents related to CRISPR sequences and associated Cas proteins, which are foundational to gene editing.

When will Philippe Horvath's induction ceremony take place?

The induction ceremony is scheduled for October 2023 in Washington, D.C.

How does Philippe Horvath's work benefit the dairy industry?

His research has improved starter cultures in the dairy industry, enhancing resistance to viral infections.

What is IFF's reaction to Horvath's induction into the Hall of Fame?

IFF expresses pride in Horvath's achievements, viewing it as a testament to their scientific innovation heritage.